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Chronic recurrent multifocal osteomyelitis (CRMO) is an auto-inflammatory disorder affecting the 
skeleton of children and adolescents. Whole body MRI (WBMRI) is key in diagnosis and follow-up of 
CRMO. Imaging protocols should include sagittal STIR of the spine, imaging of the hands and feet 
and T1 images for distinguishing normal bone marrow. CRMO lesions can be metaphyseal, 
epiphyseal and physeal – potentially causing growth disturbance and deformity. Spinal lesions are 
common, important and can cause vertebral collapse. Lesion patterns include multifocal tibial and 
pauci-focal patterns which follow a predictable presentation and course of disease. Common pitfalls 
of WBMRI include hematopoietic marrow signal, metaphyseal signal early on in bisphosphonate 
therapy and normal high T2 signal in the hands and feet. Pictorial reporting assists in recording 
lesions and follow-up over time. The purpose of this paper is to review the different WBMRI 
protocols, imaging findings, lesion patterns and common pitfalls in children with CRMO
KEYWORDS: Chronic recurrent multifocal osteomyelitis, children, whole-body magnetic resonance 
imaging, osteomyelitis, autoinflammatory
KEY MESSAGE
Whole-body MRI protocols for CRMO must include the spine, the hands and feet.
CRMO patterns on WBMRI include multifocal predominantly tibial or clavicular-spinal distribution.  
Radiologists need to be aware of the mimickers pitfalls of Whole-body MRI in CRMO. 
INTRODUCTION






























































Chronic recurrent multifocal osteomyelitis, (CRMO) also known as chronic non-bacterial 
osteomyelitis (CNO), is an auto-inflammatory disorder affecting the skeleton of children and 
adolescents (1-4). CNO can affect all bones, but it is characterized by inflammatory lesions usually 
affecting the metaphyses of long bones of the lower extremities, clavicles and spine with spontaneous 
remissions and exacerbations (1, 3-5). An important aspect of CRMO, is the presence of multifocal 
bone lesions and the possibility for complications such as vertebral fractures (2). The diagnosis of 
CRMO is traditionally one of exclusion of other diseases but current practice suggests that when 
CRMO is suspected on clinical grounds, bone biopsy should not be routine. Instead, whole-body 
imaging is indicated to determine multi-focality, for narrowing the diagnosis (3, 6).
The diagnosis of CRMO can be challenging as it shares many imaging features with other 
conditions. Bacterial osteomyelitis can mimic CRMO in patients with multiple lesions; however, soft-
tissue involvement – such as abscesses – are more often seen in bacterial osteomyelitis (7). Scurvy, a 
metabolic disorder, manifest with diffuse lesions that can be metaphyseal initially but later spread to 
the diaphysis and is associated with subperiosteal hematomas (8). Malignant aetiologies, such as 
leukaemia or osteosarcoma, can be confused with CRMO as they can display abnormal marrow 
signal. However, these aetiologies present with focal or diffuse marrow replacement instead of 
oedema (9, 10).  
In the management of suspected CRMO, Magnetic Resonance Imaging (MRI) is useful in that 
it is highly sensitive for detecting inflammatory lesions without radiation exposure; it helps to exclude 
some of the alternative diagnoses; it can reveal features  and patterns of bone involvement 
characteristic of CRMO; it provides an accurate site of involvement and provides a roadmap for 
possible biopsy; it is useful for determining response to and complications of treatment and it can 
identify complications of CRMO such as bone deformities due to early physeal closure.
Whole-Body Magnetic Resonance Imaging (WBMRI) is used in CRMO but there are 
questions regarding whether it should be a diagnostic tool, a quantitative/qualitative scoring tool, a 
treatment monitoring tool, or all of the above. Furthermore, to be able to generalise clinical findings 






























































and research results, radiologists should be performing similar WBMRI exams regarding sequences 
and planes of imaging while also keeping scan times appropriate for children. Beyond performing the 
examination in the same way, radiologists should be aware which signs are most diagnostic, what a 
typical CRMO lesion looks like and report it in a comparable manner. In order to predict outcome, 
scoring systems should not only incorporate lesion burden but also reflect susceptibility for growth 
disturbance and deformity.
WBMRI  is already established for use in CRMO because it has further advantages over 
localised imaging, in that it can reveal multifocal disease (increasing the likelihood of CRMO), 
including silent (non-painful) lesions that may have characteristic features of CRMO when the 
sentinel lesion has non-specific features. Furthermore, having images of the whole skeleton helps to 
demonstrate patterns of skeletal involvement characteristic of CRMO, e.g. ‘bilateral, symmetric 
pattern’ (2), ‘tibia multi-appendicular pattern’ or ‘clavicle pauci-axial pattern’ (11), and helps quantify 
the disease in terms of lesion load (number of lesions in a patient) and lesion severity (e.g. vertebral 
collapse, proportion of physis involved) for prognosis.
Having established the role of WBMRI in CRMO, technical considerations must be optimised 
both for minimising the time spent on the scanner and for improving sensitivity of detecting lesions 
and relevant complications. Despite reports of 40-minute scan times, the addition of sagittal imaging 
of the spine and diffusion weighted imaging (DWI) can extend scan times by up to and beyond 90 
minutes. The radiologist’s role in imaging interpretation must also be optimised, by validating 
characteristic MRI features and patterns of CRMO, highlighting pitfalls and mimickers (such as 
carpal and tarsal high signal foci), improving prognostication from MRI through determination of 
lesion ‘activity’ (signal intensities), lesion load (lesions per patient, scoring systems), lesion extent 
(proportional metaphyseal, epiphyseal and paraphyseal involvement) and lastly through standardised 
reporting for improved data collection and diagnosis.
This review summarises current knowledge with regard to important technical aspects and 
image interpretation of WBMRI for paediatric CRMO, previously presented in abstract format (12)































































Imaging parameters and Number of Stations / Scan Ranges
Imaging parameters reported for WBMRI in CRMO vary widely with respect to field of view, 
matrix and number of stations for achieving head-to-toe imaging and these are summarised in 
Supplementary Table S1, available at Rheumatology online. The number of stations scanned are 
reported to range from 4 to 8 for the coronal plane (depending on patient height) and an additional 2 
stations for imaging the spine in the sagittal plane. There are no paper reports of single station / long 
Z-axis use. 
Damasio et al, reported in a general paper on WBMRI, that acquiring images in stations with 
aligned slices and gradients allows stitching together of images, reduces scan time and makes 
repositioning unnecessary (13). Several papers of CRMO have published images that were stitched 
(Figure 1) to demonstrate the whole body of the patient (1, 2, 4, 14-16) but none provide information 
as to the usefulness of stitching for diagnosis or how to best review the images. In practice, as many 
fields as necessary should be used for maximum resolution but it is important to use the same fields in 
follow-up studies, for adequate comparison. Practical tips include scanning the abdomen and pelvis 
separately and demonstrating the clavicles in full in at least one field [either with the head-neck or the 
chest range].
Additional imaging planes and balancing time constraints 
In principle WBMRI aims for ‘maximum body coverage in the shortest possible time’ (17). 
By this definition WBMRI should involve few sequences (at best only one) and few planes (at best 
only one) (17) but the addition of “a dedicated scan of the whole spine in the sagittal plane for 
improved visualization” during WBMRI has been proposed (17). Falip et al noted that the lack of 
agreement on frequency of spinal lesions might be due to diagnostic underestimation (3) and Von 
Kalle et al noted that spinal (as well as sacral, scapular, sternal or patellar lesions) may be difficult to 
assess on the standard coronal images (2) (Figure 2a). The latter group suggested that in cases of 
known or suspected vertebral or sacral lesions, that sagittal imaging be performed to improve 






























































visualisation (2). Arnoldi et al go further in recommending routine sagittal plane scanning with T1WI 
and STIR, resulting in an additional scanning time of 11 minutes (14). The whole spine can usually be 
covered with 2 overlapping sagittal sections (1).
Routine additional imaging of the spine in the sagittal plane is important because spinal 
involvement should be considered a classic feature of CRMO (3). Damasio reported the spine as ‘the 
most frequent radiologically involved skeletal segment’ (13). Arnoldi et al reported “regular spine 
involvement of nearly a fifth” of their cohort and highlighted the role that WBMRI findings can have 
in management of CRMO (14). Numerous publications report spinal involvement: 8.4% (18), 19% 
(11) 20% (19), 26% (20), 29% (3), 33 % (13). CRMO involves the thoracic spine predominantly, 
followed by lumbar, cervical and sacral portions of the spine (5, 11, 21).
Furthermore, identification of spinal involvement is important because vertebral height loss is 
reported as the most common location of pathologic fracture in CRMO (21, 22) (Figure 2b). Falip et 
al reported vertebra plana in 22% of their patients (3) while Wipff et all reported the risk of vertebral 
fracture from CRMO lesions as 17.5% (23). Detecting spinal involvement early, is therefore 
important for preventing vertebral body fracture and resultant vertebra plana (1, 3, 5, 21) (16, 22) 
because vertebral height is not regained after treatment in CRMO (3, 21, 24). It follows that adequate 
imaging of the spine should therefore occur at the subclinical stage so that aggressive treatment (e.g. 
bisphosphonates) can be initiated to prevent deformity (kyphosis and scoliosis) (5, 20, 25).
Sequences for WBMRI in CRMO
WBMRI is intended to serve as a screening examination for revealing bone marrow oedema 
and therefore uses STIR as the default imaging sequence (17). There is also currently strong support 
for the use of T1 weighted images and recent papers reported using additional DWI in CRMO (11, 
13). Few authors use additional T2 sequences and only occasionally are regional post contrast images 
performed. A summary of the sequences reported for use in WBMRI of CRMO is provided in 
Supplementary Table S2, available at Rheumatology online. Damasio et al report that T1-weighted 
sequences are essential in imaging CRMO (13). This is because T1 hyperintensity on unenhanced 






























































sequences may suggest an alternate diagnosis including fat, blood products and proteinaceous 
material (22). T1 is most useful in CRMO for differentiating true lesions from normal bone marrow 
conversion (13). Differentiation of red (haematopoietic) marrow from a CRMO lesion may not be 
possible with STIR imaging alone as both can have a moderately high signal. T1 assists the 
radiologist because red marrow is of intermediate signal on T1 while CRMO lesions have a low 
T1 signal (26). Considering the extended scan times, especially with the routine addition of sagittal 
imaging, T1 could be added for problem solving on a lesion by lesion basis, until sequence times are 
improved all around.
There is limited published material on DWI use in CRMO. Although WB-DWI can be 
reliably performed in children at 3T (16), interpretation may be difficult due to inhomogeneous bone 
marrow signal. There is no systematic data on physiological DWI signal distribution in the bone 
marrow of children differentiated by age and anatomical location (27) but Merlini et al noted in their 
paper that DWI did not improve lesion conspicuity compared to STIR (28).  DWI may be useful to 
distinguish malignancy from CRMO in the spine but this is not universally accepted. Supplementary 
Table S3, available at Rheumatology online, in lists the papers that report on the use of DWI in 
CRMO. In summary, it is likely that there will be continued use of STIR as the default sequence until 
more sensitive or specific sequences are tested and become mainstream (already being tested by some 
research groups).
Positioning of Hands and Feet
Frequency of hand involvement reported ranges from 2–11% (Supplementary Table S4, 
available at Rheumatology online) (2, 11, 15, 23, 29). Hands are the most difficult portion of the 
skeleton to image during a WBMRI study (13, 14). There is no agreed technique for imaging the 
hands and suggestions include placing the arms and hands beside the body (which makes evaluation 
of arms and hands difficult due to artefact) (13); placing the hands on the pelvis with an additional 
body coil (1, 14); placing the hands under the buttocks for inclusion in the pelvic scanning range (11); 
or imaging the hands separately above the head (17, 30) (Figure 3a) which adds to study time 
because of the additional scan station required. The recommendation is to place the hands on the 






























































abdomen and to include them in the abdominal or pelvic portion of the WBMRI or to place the hands 
under buttocks during the pelvic portion of the WBMRI (Figure 3b) as described by Andronikou et al 
(11) thereby splaying the hands and avoiding air-skin interface artefact. Note should be made that 
according to Avenarius et al, joint fluid, bone marrow oedema-like changes, and ganglion cysts may 
mimic pathologic abnormalities in the paediatric wrist (31).
CRMO is more common in the small bones of the feet than in the hands (21) occurring in 
around 40% of CRMO cases (Supplementary Table S5, available at Rheumatology online). The 
calcaneus and talus, which are metaphyseal equivalents, are reported to be involved most often (21) 
and while most papers report that the metatarsals are only rarely involved in CRMO, Andronikou et al 
reported abnormality involving the metatarsals in 22% of patients (11). A poor anatomical match in 
the feet can justify targeted MRI (14) which includes an optional sagittal scan of each foot (17). 
Purposefully positioning both feet in the lateral view (Figure 3c) is an optional solution for the last 
station of a WBMRI (11) or adding a sagittal scan of the feet to improve visualisation of the talus and 
calcaneus. Most important is to note that MR signal abnormalities of the talus and calcaneus may not 
be pathological (Figure 3d) and need to be considered alongside other lesion identified and clinical 
findings (6, 32). Our own experience with WBMRI protocols and technical considerations is 
discussed in a prior publication (11). 
IMAGING INTERPRETATION
Classic MRI CRMO lesions
Two main imaging features of CRMO are multi-focality and the involvement of specific 
skeletal sites. These characteristic sites include the juxtaphyseal/periphyseal portions of the tibia and 
femur, the clavicle and thoracolumbar spine (5, 14)(1, 6, 25, 33)(3, 4). Clavicular involvement is 
expected to comprise 30% of all CRMO lesions (21) and is reported as the most common non-
neoplastic cause of a clavicular lesion in children and adolescents (21). These lesions typically 
involve the medial third of the clavicle with marked periosteal reaction, soft-tissue signal abnormality 
and hyperostosis (3, 21) (Figure 4 a-c). The clavicle is an atypical location for bacterial osteomyelitis, 






























































and as such, an inflammatory lesion in this location on MRI is highly suggestive of CRMO (3, 5, 14). 
Hence, even when unifocal, clavicular lesions in children and adolescents are sufficient to meet the 
Bristol criteria for CRMO (19, 25, 33).
Tibial involvement occurs in up to 71% and femoral involvement in up to 47% of patients 
(Figure 5a) (1). Von Kalle et al suggested that because individual lesions are non-specific in CRMO, 
particular combinations of multi-focal skeletal sites may offer ‘diagnostic patterns’ (2). They reported 
that ‘three quarters of the diagnoses in their patients could have been made through identification of 
multifocal, hyperintense geographic metaphyseal lesions adjacent to growth plates of the long bones 
of the lower extremities, combined with either bilateral symmetric involvement, or additional lesions 
in the spine, pelvis, clavicle and/or sternum’ (2). This typical phenotypic pattern of distribution was 
also noted by Fritz et al who reported that multifocal symmetric lesions in the lower extremities were 
important (6). Khanna et al also reported bilateral tibial disease as being common (21) (Figure 5b). 
Andronikou and colleagues identified two distinct patterns of involvement in CRMO using WBMRI: 
a more common tibio-appendicular multi-focal pattern seen in more than half of children with 
CRMO, presenting with tibial lesions, multifocal involvement and no clavicular involvement; and a 
claviculo-spinal pauci-focal pattern, seen in a third of children with CRMO and presenting with 
clavicular lesions and few other, mainly spinal, lesions with no tibial involvement (11).
Spinal involvement has more recently been recognised as a classic CRMO feature, and in 
contrast to older studies it is currently considered one of the most common sites of involvement (3) 
with a reported prevalence of up to 30% (5, 23). The thoracic spine is reported to be involved most 
often (5, 21) (Hospach 60%; Falip et al 75%) (3, 20) (Figure 2a and b).
Spinal lesions show altered MR signal intensity of the vertebral marrow and endplate 
irregularity (3, 21, 22). Spinal involvement is also reported to be multifocal in two thirds of cases 
which is further support for using WBMRI (2, 3). An important aspect of spinal CRMO, is the 
possibility for complications such as vertebral fractures (2). When multifocal, CRMO of the spine 
typically involves non-contiguous vertebrae without crossing the disc - this is considered the 
distinguishing feature of CRMO from an infectious spondylodiscitis (3, 21, 22). However, 






























































involvement of the disc in some patients has prompted a description of spinal CRMO as a 
spondylodiscitis (22). Falip et al reported disc involvement in 2 of 9 patients with spinal involvement 
(22%) and recorded contiguous vertebral involvement in 1 patient (11%) (3) while Andronikou et al 
reported disc involvement in 14% of patients (5 of their 7 patients with vertebral involvement) (11). 
According to the Bristol criteria, CRMO lesions are diagnosed irrespective of their location, 
preferably by STIR MRI and typically show bone marrow oedema, bone expansion, lytic areas and 
periosteal reaction (33). Lesions are also described as ranging from ‘ill-defined’ to ‘confluent’ bone 
marrow oedema (6, 14).  More subjective descriptions of peri-physeal CRMO lesions include ‘veld-
fire’ appearance with ‘flames’ projecting into the metaphyses (Figure 5c) (11). Periosteal reaction is 
part of the spectrum of the disease (6, 11, 14, 21) with 11% of patients demonstrating periosteal 
reaction in the study by Andronikou et al (11), as is soft-tissue inflammation (reported in up to 52% of 
children) which can be marked, mimicking a soft-tissue mass (3, 21). 
Epiphyseal and Physeal Involvement
There are ten reports mentioning involvement of the epiphysis in children with CRMO 
(Supplementary Table S6, available at Rheumatology online). Andronikou et al reported 35% 
epiphyseal involvement (11), Arnoldi et al in 46% (14) and Fritz et al in 67% of long bone sites in 
children with CRMO (6). However, epiphyseal lesions without involvement of the metaphysis are not 
currently considered ‘classic’ CRMO lesions.
Two reports also specifically describe physeal involvement by CRMO on MRI in a way that 
suggests growth arrest may occur as a complication: Falip et al described a pseudo-widening growth 
plate of the distal fibula (3) and Khanna et al described radiological crossing of the physis in CRMO 
(21) (Figure 5d). In addition to isolated reports of leg length discrepancy (34) a paper by Huber et al 
describes a series of children with growth disturbances resulting from CRMO (35). These authors 
reported significant bony deformities either important for cosmetic or functional reasons in 11/ 23 
(48%) patients with CRMO, presumably due to early physeal closure, but there is no correlation with 
imaging in this report (35). Physeal and epiphyseal lesions should be reported individually and should 






























































have additional weighting in future scoring systems because  of the possibility of complicating with 
deformity.
Mimickers: Carpal / Tarsal high signal 
High signal in the metatarsals, tarsals and carpals should be treated with caution 
because of the likelihood this represents a normal variant (31, 32) (Figure 3d). Therefore, 
recording of potential lesions in the carpal and tarsal bones should continue but not be 
attached a full weighting towards lesion load or be considered diagnostic on their own [i.e. 
without the presence of one or more other classic lesions].
Mimickers: vertebral end-plate / disc involvement
23 papers have reported data of CRMO involvement of spine in children, with incidence 
ranging from 2-43% (more often between 20% and 35%) (Supplementary Table S7, available at 
Rheumatology online, summarises 20 of those with available data). Exams should only be considered 
adequate when they have excluded spinal involvement (5). Lesions that may mimic CRMO of the 
spine range from abnormal vertebral body signal to end-plate irregularity and complications of 
CRMO that may cause confusion with other pathology include sub-endplate fracture, height loss and 
vertebra plana (5) (21) (Figure 3). According to Jansen et al, nearly half of the patients with vertebral 
fractures develop scoliosis (36).
The most typical spinal manifestation resembles spondylodiscitis, describing signal 
abnormality in the vertebral body, endplate irregularity and extension into the disc (11, 22) with disc 
signal abnormality or height loss (21). Therefore, differentiating CRMO spinal lesions from bacterial 
spondylitis and spondylodiscitis may be difficult (2). However, only rarely in CRMO are there reports 
of disease crossing a disc to involve contiguous vertebrae, which differentiates CRMO from 
infectious discitis (5) (21, 24). 
Periosteal reaction is reported accompanying spinal CRMO, but identification of any 
paravertebral mass should suggest a different diagnosis (37) (2, 24). CRMO should therefore be 






























































included in the differential diagnosis when vertebral end-plate and discs disease are identified i.e. in 
the differential diagnosis of a spondylodiscitis.
Mimickers: enchondral ossification related to cyclical bisphosphonate therapy 
Bilateral, symmetric metaphyseal high signal bands after the first course of bisphosphonate 
treatment, have been noted anecdotally (but not reported) and these may mimic disease relapse, 
particularly after the first course of bisphosphonate therapy (Figure 6a). This is in contrast to reports 
of low signal (sclerotic) lines on MRI (Figure 6b), equivalent to the radiographic “zebra-line” 
appearance which affect mainly the distal femora and proximal tibiae and fibulae (Figure 6c) (38-40). 
The sclerotic zebra lines vary in spacing according to the age of the patient, rate of growth, interval 
between cycles of bisphosphonates and location of the metaphysis (41). The high signal in the 
metaphyses related to bisphosphonate treatment, most likely represents Pamidronate-related increased 
conspicuity of the zone of endochondral ossification, analogous to the mandibular growth zone T2 
high signal (42).
Scoring systems and recording of disease burden 
The RINBO scoring system is the only dedicated scoring system proposed for WBMRI 
findings of CRMO (14). It has been shown to be a significant predictor for the presence of clinically 
active lesions, which supports the idea of RINBO offering a means to grade the intensity of disease 
and to simplify the evaluation of progression, stability or remission during the course of the disease 
(14). The RINBO score allocates points (to a maximum of 10) according to increasing numbers of 
lesions (out of a 3-point scale), increasing size of lesions (out of a 3-point scale), any acute or chronic 
inflammatory reactions of the periosteum / soft tissues (1 point for each) and for any vertebral body 
signal and deformation (1 point for each) (14). The creators of the score, indicate that the purpose of 
RINBO ‘is to encourage standardized reporting, improve reproducibility and ease stratification of 
WBMRI findings’ to improve therapeutic decisions (14). However, considering that clinical activity is 
already evident through visual analogue scaled (VAS) scores, the usefulness of correlating the 
RINBO score with clinically active lesions is not clear (14). This is especially because patients 






























































present with pain, and management is customised to this pain. From a prognostic perspective, only 
spinal involvement is weighted into the score, whereas from a diagnostic perspective, no weighting is 
given to the likelihood of CRMO based on the distribution pattern (14). 
Future iterations of RINBO or an alternative scoring system should aim to correlate with 
outcome (i.e. deformity), for it to be used as a prognostic tool. To this end, the likelihood of future 
physeal fusion with growth restriction / deformity and possibility for vertebral collapse/spinal 
deformity should be weighted into the score. Furthermore, the scoring system should provide 
weighting depending on whether lesions are ‘classic’, ‘probable’ and ‘possible’ and downgrade 
carpal/tarsal bone signal abnormalities. A standardised reporting system could also reflect lesion load 
and spinal involvement in more detail than RINBO currently does, (e.g. actual lesion load rather than 
categories of lesions numbers as recorded in RINBO). 
To achieve this one of the several anatomic maps have been published to demonstrate 
proportional lesion distribution in CRMO, which may also be used to record individual findings and 
may assist in revealing diagnostic and prognostic distributional patterns of disease (2, 6, 11, 23, 29, 
43). Such a pictorial tick-sheet could assist in revealing WBRMI distribution patterns and inform 
modifications of scoring systems to indicate the likelihood of CRMO as the diagnosis. Phenotypic 
groupings (e.g. by Wipff et al and Andronikou et al) have not only correlated with severity of 
inflammatory disease but were also linked to outcome, likelihood of response to treatment and relapse 
rates, and include details of peri-physeal lesions which should in turn influence scoring (11, 23). Most 
clinicians who have expertise in CRMO currently use WBMRI to prognosticate on need for 
immunomodulatory therapies (e.g., pamidronate or anti-TNF) and depending on sites involved 
potential long-term outcomes at least after 6 -12 months of treatment to assess response. WBMRI 
remains for clinicians, in the absence of other clinical or laboratory markers, the most important tool 
to help in management of children and adolescents with CRMO.
Finally, work is in progress for developing artificial intelligence platforms for automated lesion 
detection from MRI, scoring and decision making, but the numbers of children with CRMO and 






























































issues with ground truth especially when trying to differentiate lesions from normal marrow without 
biopsy, are proving to be obstacles at the initial stages.
CONCLUSION
WBMRI has found its role in the diagnosis and management of CRMO in children. This 
review summarises technical aspects to assist diagnosis while keeping scan times practical and 
describes MRI features of CRMO. Sagittal STIR imaging of the spine should be routine in CRMO 
while improved imaging of the hands and feet can be achieved by simple positioning manoeuvres. T1 
can be used to differentiate pathology from normal red marrow in children. Important areas to 
highlight, include that CRMO lesions are not only metaphyseal but also epiphyseal and physeal, 
because these can cause growth disturbance and deformity; that spinal lesions are common and 
important because they cause vertebral collapse; that there are typical CRMO patterns on WBMRI 
including multifocal tibial pattern (bilateral, symmetric metaphyseal lesions, around the knee) and the 
paucifocal pattern with few lesions involving the clavicles and spine, with predictable presentation 
and course of disease. The review also highlights important WBMRI pitfalls such as marrow signal, 
metaphyseal signal appearances early on in bisphosphonate therapy and signal in the hands and feet.
Using a pictorial reporting format for recording both first-time and follow-up of CRMO lesions on 
WBMRI can be partnered with a scoring system that reflects not only the lesion load but also the 
lesion distribution and likelihood for growth disturbance / deformity. 
Funding: No specific funding was received from any funding bodies in the public, commercial or not-
for-profit sectors to carry out the work described in this manuscript. 
Disclosure statement: A.V.R. has received speakers fees/honoraria from SOBi Ltd. The other authors 
have declared no conflicts of interest.































































Figure 1. Representative coronal image from a ‘stitched’ coronal STIR WBMRI in an 
adolescent with CRMO. This allows review of the entire body by scrolling from anterior to 
posterior. The patient shows bilateral symmetric periphyseal signal abnormality at the distal femora 
and proximal tibiae, as well as a lesion of the right distal tibia (open circle).
Figure 2. CRMO involving the vertebral column
(a) Coronal STIR component of a WBRMI scan demonstrating abnormal high signal in multiple 
non-contiguous vertebral bodies without crossing the disc (arrows), in keeping with 
additional lesions in a child with a diagnosis of CRMO. 
(b) Sagittal STIR demonstrating multifocal thoracic vertebral CRMO lesions in a child. Over and 
above the signal abnormality there is endplate collapse and vertebral height loss with wedging 
in some. The height loss is not expected to be regained in this condition.
Figure 3. Technical aspects of imaging the hands and feet
a) One option to achieve whole-body coverage during STIR WBMRI is an additional station for 
imaging the hands. This involves stretching the hands out above the head (supine or prone) 
but adds to the study time and results in artefact at the air-soft tissue interface (not show 
here). In this patient, abnormal high signal is demonstrated in the proximal phalanx of the 
right ring finger (arrow) and possible lesions in the distal ulnar metaphyses, which provide 
the additional lesions required for making the diagnosis of CRMO. 
b) A proposed alternative method of imaging the hands, involves purposefully placing them 
under the buttocks at the start of the examination for inclusion during imaging of the 
abdomino-pelvic station of the WBMRI. Note that a coronal view of the hands is achieved 
with the fingers adequately splayed and that air-skin interface artefact is avoided, while no 
additional scan time is required.






























































c) Placing the feet in the externally rotated position during STIR WBMRI scanning of the last 
station, provides a sagittal view of the calcaneus and improved visualisation of the bones of 
the feet compared to direct coronal views.
d) Sagittal view of the foot from a WBMRI in a child with CRMO demonstrating high signal 
foci at multiple sites including the calcaneus which may or may not represent pathology.
Figure 4 Coronal STIR WBMRI demonstrating clavicular involvement considered 
characteristic of CRMO
(a) Abnormal high signal is noted in the medial aspect of the left clavicle (arrow) compared to 
the right in this child with CRMO.
(b) Abnormal high signal is noted in the medial and middle thirds of the right clavicle (arrow) in 
this child with CRMO
(c) Abnormal high signal and marked expansion of the right clavicle (arrow) is noted in this child 
with CRMO
Figure 5. Typical imaging findings of CRMO involving the peri-physeal regions and physes of 
the lower limbs
(a) Coronal STIR image extracted from a WBMRI study in a child with CRMO demonstrating 
abnormal high signal at the most common site of involvement in CRMO which is the 
metaphysis at the distal femur (in this case on the right). In this child there is also 
involvement of the right distal femoral epiphysis.
(b) Coronal STIR image extracted from a WBMRI in an adolescent with CRMO demonstrating 
the typical: ‘hyperintense geographic metaphyseal lesions adjacent to growth plates of the 
long bones of the lower extremities’ 
(c) Typical CRMO appearances on STIR WBMRI in a child with CRMO, demonstrating the 
‘veld-fire’ appearance of abnormal signal in the peri-physeal - metaphyseal and epi-physeal 
(white arrow) - part of the right distal tibia and the ‘flame-shaped’ abnormal high signal 






























































lesion in the left tibial metaphysis (black arrow). Note that while the (physeal) aspect of the 
signal abnormality is well defined, the internal (diaphyseal) margin is not. 
(d) Coronal STIR providing a distal tibial view of a CRMO lesion involving the metaphysis and 
epiphysis of the right distal tibia with destructive changes involving the physis itself, 
concerning for a future growth disturbance or deformity.
Figure 6  Metaphyseal bands associated with pamidronate therapy
(a) Coronal STIR WBMRI in a child who received pamidronate treatment for the first time, 
demonstrating a symmetric thick band of high signal in the distal femoral metaphyses (thin 
arrows), separable from the thinner linear band of high signal of the physis (thick arrows). 
The non-physeal aspect of the signal has a sharp margin, which differentiates this from the 
‘veld-fire’ appearance or ‘flame-shaped’ CRMO lesions. It is thought that this represents the 
visible expanded zone of endochondral ossification (present early on in Pamidronate therapy), 
which has a reported high signal on T2.
(b) A coronal STIR image from a WBMRI study in a patient with CRMO who received a single 
dose of pamidronate demonstrates a typical Pamidronate line which is seen as a thin, low-
signal linear band mirroring the metaphyseal edge (arrow), which (as a result of growth) has 
migrated some distance away from the physis (a high signal band).
(c) A coronal STIR image from a WBMRI study in a patient with CRMO who received multiple, 
evenly-spaced, doses of pamidronate. The image demonstrates the typical zebra-line pattern 
(rectangle). Note that the last course was some time previously, as noted by the large distance 
between the most distal pamidronate line and the high signal physis (arrow). 
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Supplementary Table S1:  Summary of routine sequences and imaging parameters for WBMRI in CRMO
References Sequences Field of view Matrix Stations Comments







Kennedy 2012 (44) Coronal STIR 5 stations Case report
Von Kalle 2013 (2) Coronal STIR Max 500mm 384x269 4-5 stations
Falip 2013 (3) Coronal T1 STIR 4-5 stations Limited 
information on 
technique
Von Kalle 2013 (2) Coronal STIR Max 500mm 384x269 4-5 stations











Leclair 2016 (16) Coronal STIR 500x500mm 448x336 6-8 depending on 
height
Paper mainly on 
DWI








General paper on 
WBMRI in 
children
Andronikou 2019 (11) Coronal STIR 450X310 5-7 depending on 
height
STIR: Short Tau inversion recovery; CRMO: Chronic Recurrent Multifocal Osteomyelitis; WBMRI: Whole-body 
Magnetic Resonance Imaging








































































Used different sequences 
in different patients
Fritz 2009 (6) Coronal
T1















T1 Coronal / Sagittal





Regional images in 
abnormal areas only










T1 Coronal / Sagittal
Leclair 2016 (16) Coronal/ Axial DWI Axial
Moussa 2017 (47) Coronal
Additional regional 
sequences including post 
gad





General paper on WB-
MRI in children








Andronikou 2019 (11) Coronal
STIR: Short Tau inversion recovery; CRMO: Chronic Recurrent Multifocal Osteomyelitis; WBMRI: Whole-
body Magnetic Resonance Imaging



































































Technique used, if specified ADC Result Comments












Yes DWI can reliably detect 
and characterise lesions
Sagittal and coronal 
images had marked 
artefact 














3T, slice 4mm reconstructed 
in coronal plane 5mm and as 









substantially elevated in 
CRMO lesions, 
Problems with artefact 
(2 patients DWI non-
diagnostic)
16 patients
Did not look at 
sensitivity of DWI 
compared to STIR 






Merlini 2017 (28) Axial Whole 
body
No DWI did not enhance 
lesion conspicuity 
compared to STIR
General paper on 
WBMRI in 
children only 8 
children with 
CRMO (n=54)
Arnoldi 2017 (14) Axial Not 
known
B values: 800 ? Not presented Mention of DWI 
in the discussion; 
showed high 





Andronikou 2019 (11) Axial Whole 
body
Head: 7,400 ms TR, 89 ms 
TE, B-values of 0 and 800,  
230x230 mm FOV, 25 
section of 4 mm thick with a 
1.2 mm gap
Body: 5,320 ms TR, 64 ms 
TE, B-values of 0 and 800, 
300x420mm FOV, 40 
sections of 4 mm thick with a 
0.4 mm gap.
No Not used for 
analysis
STIR: Short Tau Inversion Recovery; CRMO: Chronic Recurrent Multifocal Osteomyelitis; WBMRI: Whole-body Magnetic Resonance 
Imaging; DWI:  Diffusion-weighted imaging; FOV: Field of view; ADC:  Apparent Diffusion Coefficient; MIP: Maximum Intensity 
projection; TR: Repetition Time






























































Supplementary Table S4: Summary of WBMRI descriptions of hand involvement in children with CRMO
References Hands comment Hand technique
Girschick 2004 (29) 2% Phalanges
(of 30 patients)
Darge 2008 (17) WBMRI review
Not CRMO paper
Different scan stations are head 
and neck, thorax and upper arms, 
abdomen/pelvis and fore- arms, 
thighs and hands and the calves 
and feet. 
For improved depiction of the upper extremities, the arms can be 
placed above the head. 
This can also be done with repositioning the patient in prone 
position with outstretched arms above the head. 
Both measures entail adding an imaging stage and thus, increase 
the scan duration. 
Khanna 2009 (21) Review Short tubular bones typically demonstrate lytic lesions with 
surrounding sclerosis, periosteal reaction, and associated soft-
tissue inflammation
Guérin-Pfyffer 2012 (15) 1/9 (11%) hand
von Kalle 2013 (2) 1/53 (2%)
Voit 2015 (1) Upper arms were positioned parallel to the chest, and lower arms 
Hands were positioned upon the pelvis covered by an additional 
body coil 
Wipff 2015 (23) 2% (of 178)
Damasio 2016  (13) Review WBMRI Arms at the sides
Larger children: arms sometimes not included in the scan field - 
makes evaluation of arms and hands difficult due to artefacts. 
In some cases, additional examination of the arms, placed above 
the head [Ley Eur J Radiol 70(3):442–451]
Roderick 2016 (19) 30 with WBMRI
Arnoldi 2017 (14) Hard to adequately delineate 
elbows, hands or feet in some 
exams
Upper arms were positioned parallel to the chest, lower arms and 
hands were positioned upon the pelvis covered by an additional 
body coil.
Taddio 2017 (25) Review Majeed syndrome (more severe phenotype than CRMO) typically 
involves the small bones of the hands and feet
Andronikou 2019 (11) 3/37; 8% 8 lesions of the phalanges
STIR: Short TI inversion recovery; CRMO:  Chronic Recurrent Multifocal Osteomyelitis; WBMRI: Whole-body Magnetic 
Resonance Imaging.






























































Supplementary Table S5: Summary of the involvement of the feet in children with CRMO
References Feet Comment Feet technique
Darge 2008 (17) Not CRMO paper Sagittal scan of each foot is optional.
Khanna 2009 (21) Review CRMO is more common in the small bones of the feet than 
in the hands 
It can involve the tarsal bones e.g. calcaneus and talus, 
which are metaphyseal equivalents 
von Kalle 2013 (2) 23/53 (43 %) feet 
Metatarsal (n = 27) 
Cuneiform (n = 25)
Navicular (n = 21) 
93/513 lesion (18%) 
Small punctiform areas of high signal intensities are 
common in the bone marrow of children, especially in the 
feet - considered remnants of red marrow 
Lesions in metatarsals, rarely in CRMO
Walsh 2015 (34) 7/34 metatarsal 
4/34 talus 
2/34 Calcaneum
Wintrich 2015 (43) 12/32 (38%) foot
Most frequently affected 
region was the foot
Talus 5th, tarsals 6th, calcaneus 7th and metatarsals 9th most 
common out of 15 bones with CRMO lesions 
Wipff 2015 (23) 7% (of 178)
Leclair 2016 (16) 1/16 (6%)
Roderick 2016 (19) 10% of lesions 16 lesions small bone of foot
Moussa 2017 (47) 5/7 talar (71%) 1 x talar and calcaneal
1x foot involvement (intertarsal, meta-tarsophalangeal, talar 
and calcaneo-navicular joints)
Taddio 2017 (25) Review Majeed syndrome (more severe phenotype than CRMO) 
typically involves the small bones of the hands and feet
Arnoldi 2017 (14)  Hard to adequately delineate elbows, hands or feet in some 
exams
Poor anatomical match in the feet can justify targeted MRI 






Phalanges of the feet bilateral in 67%. 
All patients with bilateral metatarsal lesions were noted to 
have as a minimum the same metatarsal affected on both 
sides
CRMO: Chronic Recurrent Multifocal Osteomyelitis; WBMRI: Whole-body Magnetic Resonance Imaging.






























































Supplementary Table S6: Summary of papers reporting involvement of the epiphysis in children with 
CRMO
References Epiphysis comment
Anderson 2003 (48) Single case from 3 - Multiple epiphyseal and metaphyseal regions, right shoulder, 
left wrist, right hip, right tibia, right distal femoral condyle, left sternoclavicular 
joint, fourth costosternal joint, left talocalcaneal joint, T8, left T3/4 costovertebral 
joint, left mid-tarsus, right first metatarsal 
Fritz 2009(6) In 101 patients
In tubular bones (70 anatomic sites), metaphysis (86%, 60 of 70) and epiphysis 
(67%, 47 of 70) were involved. 
Beck 2010 (18) Single patient - Further lesions are seen in the metaphyses of both proximal and 
distal femurs, proximal tibias and fibulas predominantly in the 
epiphyses/metaphyses 
Guérin-Pfyffer 2012 (15) ‘Both metaphysis and epiphysis of long bones were involved’
Costa-Reis 2013 (5) It can affect all bones, but lesions usually occur at the metaphyses and epiphyses of 
long bones, with a predilection for the lower extremities 
Habibi 2013 (49) Case report
This showed multiple areas of high-signal lesions involving distal femur, tibial 
metaphyses and epiphyses, distal fibulae, bilateral sacral alae, distal right radius, 
bilateral medial clavicles and collapse of multiple cervical and thoracic vertebral 
bodies 
Ract 2015 (50) Single patient with metaphyseal abnormality spreading to epiphysis
Moussa 2017 (47) One patient had epiphyseal lesions and metaphyseal involvement. 
Arnoldi 2017 (14) Of 33 patients - The most common anatomic locations were long tubular bones (85 
% metaphyseal, 46 % epiphyseal, 7 % diaphyseal)
Andronikou 2019 (11) 35% of all lesions were epiphyseal
Commonest site was the distal metaphysis (42% of long bone lesions), except at the 
humerus, where the
proximal metaphysis was more common
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